stockrowHarmony Biosciences Holdings, Inc.
HRMY Healthcare Biotechnology
Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024.
- Revenue
- +12.3%
- EPS
- −6.24%
- Free cash flow
- −29.4%
- Total debt
- −11.5%
Quarter to September 2026, against a year earlier
Follow HRMY
Alert me
Harmony Biosciences Holdings, Inc. (HRMY) Revenue growth
Harmony Biosciences Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 19.8%, down 1.7 percentage points from fiscal 2025 (21.5%). Over the past ten years it has ranged from −96.3% (fiscal 2019) to 2,564.6% (fiscal 2020); the current reading is higher than 29% of that period. That is above the Biotechnology industry median of 6.76% and above the Healthcare sector median of 7.98%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 21.5% | (1.29) |
| FY2024 | 22.8% | (10.13) |
| FY2023 | 32.9% | (10.42) |
| FY2022 | 43.4% | (47.86) |
| FY2021 | 91.2% | (2,473.38) |
| FY2020 | 2,564.6% | 2,660.84 |
| FY2019 | −96.3% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 12.3% | (18.02) |
| Jun 2026 | 30.3% | 13.73 |
| Mar 2026 | 16.6% | (4.53) |
| Dec 2025 | 21.1% | (7.59) |
| 23 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| VIR Vir Biotechnology, Inc. compare | 1,696.0% |
| HRMY Harmony Biosciences Holdings, Inc. | 19.8% |
| FTRE Fortrea Holdings Inc. compare | −3.38% |
| SRPT Sarepta Therapeutics, Inc. compare | −19.0% |
| MESO Mesoblast Limited compare | −26.5% |
| TRVI Trevi Therapeutics, Inc. compare | — |
| MAZE Maze Therapeutics, Inc. compare | — |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
| REPL Replimune Group, Inc. compare | — |
| Biotechnology industry median | 6.76% |
| Healthcare sector median | 7.98% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|